Current and Emerging CAR T-Cell Therapies in Cancer Care

Hear from the experts on how the latest clinical data inform the use of CAR T-cell therapies across hematologic malignancies. Review their insights with an on-demand webcast adapted from a live webinar along with downloadable slidesets 2 expert commentaries and a podcast.

Share

Program Content

Activities

CAR T Q&A
Expert Answers to HCP Questions on CAR T-Cell Therapy
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2021

Expires: July 18, 2022

Pearls: CAR T Q&A
Podcast Pearls: Expert Answers to HCP Questions on CAR T-Cell Therapy
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2021

Expires: July 18, 2022

Activities

CAR T-Cell Therapy
Current and Emerging CAR T-Cell Therapies in Cancer Care
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2021

Expires: July 08, 2022

Activities

CAR T: Lymphomas
CAR T-Cell Therapy in Lymphoma: Current and Emerging Clinical Trial Evidence
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2021

Expires: June 15, 2022

CAR T: Myeloma
CAR T-Cell Therapies for Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2021

Expires: June 15, 2022

CAR T: ALL/Toxicities
CAR T-Cell Therapies for ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2021

Expires: June 15, 2022

<i>EP</i>: CAR T
ExpressPoints: Current and Emerging CAR T-Cell Therapies in Cancer Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 18, 2021

Expires: June 17, 2022

Activities

CAR T for R/R MM
Adding Idecabtagene Vicleucel to the Treatment Armamentarium for Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2021

Expires: June 01, 2022

Delayed CAR T-Cell AEs
Identifying and Managing Delayed Adverse Events Associated With CAR T-Cell Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2021

Expires: August 04, 2022

Faculty

cover img faculity

Caron A. Jacobson, MD

Assistant Professor
Division of Medical Oncology
Department of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb